Toripalimab-tpzi
25-494
Phase 2 small_molecule active
Quick answer
Toripalimab-tpzi for Squamous Cell Carcinoma is a Phase 2 program (small_molecule) at Coherus Oncology with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Coherus Oncology
- Indication
- Squamous Cell Carcinoma
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active